2011
DOI: 10.5603/nmr.2011.00022
|View full text |Cite
|
Sign up to set email alerts
|

Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO — a selected review

Abstract: Cu-ATSM appears superior in terms of imaging performance, calling for industrial and clinical development of this innovative radiopharmaceutical.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
53
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(53 citation statements)
references
References 39 publications
0
53
0
Order By: Relevance
“…Recently, the feasibility of this PET imaging agent for in vivo detection of hypoxia in advanced lesions was successfully evaluated in rabbits with advanced atherosclerosis (15). However, compared with 64 Cu-ATSM, 18 F-fluoromisonidazole has 2 major disadvantages: lower cellular uptake and slower washout from normoxic tissue (20). The more efficient uptake and washout kinetics of 64 Cu-ATSM in hypoxic and normoxic cells offer the possibility of a faster and more selective means of detecting hypoxia by PET imaging.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, the feasibility of this PET imaging agent for in vivo detection of hypoxia in advanced lesions was successfully evaluated in rabbits with advanced atherosclerosis (15). However, compared with 64 Cu-ATSM, 18 F-fluoromisonidazole has 2 major disadvantages: lower cellular uptake and slower washout from normoxic tissue (20). The more efficient uptake and washout kinetics of 64 Cu-ATSM in hypoxic and normoxic cells offer the possibility of a faster and more selective means of detecting hypoxia by PET imaging.…”
Section: Discussionmentioning
confidence: 99%
“…64 Cu-ATSM imaging would overcome this limitation. 18 F-fluoromisonidazole is one of the most commonly used investigational PET agents for the measurement of tumor hypoxia (20). Recently, the feasibility of this PET imaging agent for in vivo detection of hypoxia in advanced lesions was successfully evaluated in rabbits with advanced atherosclerosis (15).…”
Section: Discussionmentioning
confidence: 99%
“…Hypoxia can result in an increase in tumor aggressiveness, failure of local control, and activation of transcription factors that support cell survival and migration [57]. …”
Section: Clinical Applicationmentioning
confidence: 99%
“…In hypoxic cells, the radical is further reduced and then binds to intracellular macromolecules, irreversibly trapping it within the cell (49 (77,78). To our knowledge, there is only one similar study in NPC which was published as an abstract (79).…”
Section: Nitroimidazolesmentioning
confidence: 97%